Aloka Trivitron Medical Technologies Private Limited, a active private limited company, was established on 24 September 2007 in Sriperumputhur, Tamil Nadu, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U33111TN2007PTC064858. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹20.00 Cr.
It upholds a compliant status. Employing 16 professional, Its leadership includes Chandra Ganjoo (Additional Director), Kavya K Velu (Additional Director). Past directors included Takuya Maeda, Keiichi Tanamura, Machida Masaaki. It holds ₹70.00 K open charges and no settled loans. Its latest AGM occurred on 20 September 2022, with the balance sheet filed on 31 March 2022. It is based at A5 Sipcot Industrial Park Irrungattukottai, Sriperumputhur, Tamil Nadu, 602117.
U33111TN2007PTC064858
064858
24 September 2007
₹20.00 Cr
₹20.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Aloka Trivitron Medical Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandra Ganjoo | Additional Director | 06 Mar 2025 | Current |
| Kavya K Velu | Additional Director | 11 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 22 Jun 2017 | Past |
| Pramod Abcsdd | Director | 31 Mar 2018 | Past |
| Pramod Abcsdd | Managing Director | 02 Jan 2013 | Past |
| Pramod Abcsdd | Additional Director | 22 Jun 2017 | Past |
| Pramod Abcsdd | Additional Director | 22 Oct 2020 | Past |
| Pramod Abcsdd | Director | 21 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aloka Trivitron Medical Technologies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 65.02% decrease. The company also saw a slight improvement in profitability, with a 0.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Aloka Trivitron Medical Technologies had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹70,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2017 | State Bank Of India | ₹0.07 M | Open |
Explore comprehensive loan charge details -
Aloka Trivitron Medical Technologies has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aloka Trivitron Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aloka Trivitron Medical Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kavya K Velu was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2025 & has been associated with this company since 4 months 12 days . was recorded as a recent event.
Chandra Ganjoo was appointed as a Additional Director was appointed as a Additional Director on 06 Mar 2025 & has been associated with this company since 9 months 17 days . was recorded as a recent event.
The activity Aloka Trivitron Medical Technologies Private Limited last Annual general meeting of members was held on 20 Sep 2022 as per latest MCA records. was completed.
Progress on Aloka Trivitron Medical Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chennai. was documented.
A charge with State Bank Of India amounted to Rs. 0.01 Cr with Charge ID 100093636 was registered on 25 Apr 2017. was recorded as a recent event.
Progress on Aloka Trivitron Medical Technologies Private Limited was registered on 24 Sep 2007 with Roc Chennai & aged 18 years 2 months as per MCA records. was documented.
GSK Velu, founder of both companies, is looking at aggressively acquiring pathology chains and medical equipment makers in these markets through funds to be mobilised from various channels, including IPOs over the next couple of years. .
Kiran Medical Systems introduced Elite Digital C-arm & Felicia Digital Mammography system at Arab Health Convention in Dubai. Elite Digital offers high resolution imaging with 1K X 1K Flat Panel Detector and 16 bit processing. Felicia is designed for less painful mammograms with advanced technology. Kiran's goal is to make World-Class Healthcare Affordable and Accessible. Trivitron Group's focus on R&D and manufacturing has led to the launch of these products, with more to come in 2019..
Neuberg probably has the size and profits to list even today. However, we feel the fundamentals need to be more strong, says Velu.
The CIN of Aloka Trivitron Medical Technologies Private Limited is U33111TN2007PTC064858.
Aloka Trivitron Medical Technologies Private Limited is headquartered at A5 Sipcot Industrial Park Irrungattukottai, Sriperumputhur, Tamil Nadu, 602117.
Aloka Trivitron Medical Technologies Private Limited was incorporated on 24 September 2007.
The current directors of Aloka Trivitron Medical Technologies Private Limited are
The primary industry of Aloka Trivitron Medical Technologies Private Limited is Manufacturing.
Aloka Trivitron Medical Technologies Private Limited is unlisted.
The authorized capital of Aloka Trivitron Medical Technologies Private Limited is ₹20.00 Cr, and the paid-up capital is ₹20.00 Cr.
The compliance status of Aloka Trivitron Medical Technologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX